These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8366297)

  • 1. Rapid, automated enzyme immunoassay for MCA with the Cobas Core Roche immunochemistry analyser.
    Henne V; Maurer A
    Int J Biol Markers; 1993; 8(2):133-7. PubMed ID: 8366297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of the new tumor marker MCA in the follow-up of patients with mammary carcinoma.
    Müller-Brand J; Mäcke H
    Int J Biol Markers; 1993; 8(2):130-2. PubMed ID: 8366296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the COBAS CORE Immunoassay for measuring prostate-specific antigen (PSA)--multi-centre study results. The PSA Study Group.
    Schambeck CM
    Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):541-7. PubMed ID: 8547440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemistry and molecular biology of MCA.
    Maurer A; Burckhardt J
    Int J Biol Markers; 1993; 8(2):108-12. PubMed ID: 8366293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancer.
    Bombardieri E; Gion M; Mione R; Dittadi R; Bruscagnin G; Buraggi G
    Cancer; 1989 Feb; 63(3):490-5. PubMed ID: 2643453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan.
    Seregni E; Crippa F; Botti C; Bellotti MG; Bogni A; Pizzichetta M; Bombardieri E
    Int J Biol Markers; 1993; 8(2):124-9. PubMed ID: 8366295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3.
    Miserez AR; Günes I; Müller-Brand J; Walther E; Fridrich R; Mäcke H
    Eur J Cancer; 1991; 27(2):126-31. PubMed ID: 1827273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCA performance in preoperative breast cancer patients.
    Donadeo A; Micelli G; Quaranta M; Atlante A; Schittulli F
    Anticancer Res; 1995; 15(2):527-9. PubMed ID: 7763034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin-like carcinoma-associated antigen (MCA) in tissue and serum of patients with breast cancer: clinical applications in prognosis and disease monitoring.
    Molina R; Jo J; Filella X; Zanon G; Grau JJ; Joseph J; Bedini JL; Biete A; Ballesta AM
    Int J Biol Markers; 1993; 8(2):113-23. PubMed ID: 8366294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer.
    Horgan PG; Byrne J; O'Donoghue J; Mooney E; Grimes H; Given HF
    Ir J Med Sci; 1997; 166(4):215-6. PubMed ID: 9394068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of mucinous carcinoma-associated antigen (MCA) tests in breast carcinomas.
    Günes I; Miserez AR; Müller-Brand J; Maecke H
    Int J Biol Markers; 1992; 7(4):222-4. PubMed ID: 1491177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of mucin-like associated antigen (MCA) in neoplasms of the mammary gland].
    Kopczyński Z; Stachowicz A; Kociałkowski K; Grodecka-Gazdecka S
    Ginekol Pol; 1993 Feb; 64(2):87-92. PubMed ID: 8359732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study on serum levels of mucinous like cancer antigen (MCA) in patients with breast disease: comparison with CEA.
    Boccardo F; Bombardieri E; Zanardi S; Valenti G; Zanaboni F; Valtolina M; Seregni E; Crippa F
    Int J Biol Markers; 1991; 6(1):12-20. PubMed ID: 1856512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum MCA, CA 125 and CA 19.9 determination in primary breast cancer.
    Yenisey C; Güner G
    Biochem Soc Trans; 1996 May; 24(2):302S. PubMed ID: 8736960
    [No Abstract]   [Full Text] [Related]  

  • 15. Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer.
    Steger GG; Mader R; Derfler K; Moser K; Dittrich C
    Klin Wochenschr; 1989 Aug; 67(16):813-7. PubMed ID: 2796251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.
    Rasoul-Rockenschaub S; Zielinski CC; Kubista E; Vavra N; Pospischil E; Staffen A; Czerwenka K; Aiginger P; Spona J
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1067-72. PubMed ID: 2759162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of MUC1 in breast cancer patients. A method comparison study.
    Bon GG; van Kamp GJ; Verstraeten RA; von Mensdorff-Pouilly S; Hilgers J; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):67-75. PubMed ID: 10221613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mucinous carcinoma associated antigen (MCA) levels in patients with breast cancer.
    Migali E; Ozzola G; Mariotti D; Ghezzi P; Rinaldini M; Magnanini S
    Int J Biol Markers; 1992; 7(1):61-4. PubMed ID: 1583350
    [No Abstract]   [Full Text] [Related]  

  • 19. MCA serum determination in breast carcinoma patients for the diagnosis of bone metastases.
    Dominguez-Gadea L; Martin-Curto LM; Crespo A; Avila C
    Int J Biol Markers; 1993; 8(4):203-7. PubMed ID: 8138659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients.
    Jezersek B; Cervek J; Rudolf Z; Novaković S
    Cancer Lett; 1996 Dec; 110(1-2):137-44. PubMed ID: 9018092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.